Dr. Luke Laffin and Dr. C. Michael Gibson Discuss: Kardinal: A Phase 2 Study of Tonlamarsen For the Treatment of Uncontrolled Hypertension March 28, 2026 2026 | ACC | Trial LaffinDownload Disclosures: TBD Article Navigation Dr. Deepak Bhatt and Dr. C. Michael Gibson Discuss: Prevalence and Clinical Impact of Hypercortisolism in Individuals With Resistant Hypertension: Primary Results From the Momentum Study Dr. Byeong-Keuk Kim and Dr. C. Michael Gibson Discuss: Intensive Low-Density Lipoprotein Cholesterol Targeting in Patients With Atherosclerotic Cardiovascular Disease
